Cancer Therapies: Technologies and Global Markets
- The global cancer therapy market will increase from $40.0 billion in 2007 to an estimated $47.3 billion by the end of 2008. It should reach $110.6 billion in 2013, a compound annual growth rate (CAGR) of 18.5%.
- Breast cancer therapy is the largest market with about $11.0 billion in sales in 2007. This is expected to increase to $12.0 billion by the end of 2008 and $26.5 billion in 2013, for a CAGR of 16.4%.
- Target therapy dominated in 2007 with a 45% share of the total cancer therapy market. This is expected to increase to 48% by the end of 2008 and 62.5% in 2013.
The total worldwide cancer drug market approached $14.8 billion in 2000.
Growing at an average annual rate (AAGR) of 12.5%, this market is expected to exceed $26.7 billion in 2005.
Established product lines currently constitute nearly 90% of the market, but will grow at only a 6.6% AAGR through the period.
Innovative therapies, climbing at an AAGR of 40.2%, will reach $8.6 billion in 2005, representing 32% of the total market.